Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.

<h4>Background</h4>Understanding the actual prevalence of COVID-19 transmission in the community is vital for strategic responses to the pandemic. This study aims to estimate the actual infection of COVID-19 through a seroprevalence survey and to predict infection fatality rate (IFR) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Olivia Herlinda, Adrianna Bella, Gita Kusnadi, Dimitri Swasthika Nurshadrina, Mochamad Thoriq Akbar, Sofwatun Nida, Ngabila Salama, Iwan Ariawan, Diah Saminarsih
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261931&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162779932065792
author Olivia Herlinda
Adrianna Bella
Gita Kusnadi
Dimitri Swasthika Nurshadrina
Mochamad Thoriq Akbar
Sofwatun Nida
Ngabila Salama
Iwan Ariawan
Diah Saminarsih
author_facet Olivia Herlinda
Adrianna Bella
Gita Kusnadi
Dimitri Swasthika Nurshadrina
Mochamad Thoriq Akbar
Sofwatun Nida
Ngabila Salama
Iwan Ariawan
Diah Saminarsih
author_sort Olivia Herlinda
collection DOAJ
description <h4>Background</h4>Understanding the actual prevalence of COVID-19 transmission in the community is vital for strategic responses to the pandemic. This study aims to estimate the actual infection of COVID-19 through a seroprevalence survey and to predict infection fatality rate (IFR) in Tanjung Priok, the hardest-hit sub-district by the COVID-19 in Jakarta, Indonesia.<h4>Methods</h4>We conducted a venous blood sampling (phlebotomy) to 3,196 individuals in Tanjung Priok between Nov 23, 2020, and Feb 19, 2021 to detect their antibodies against SARS-CoV-2. Using an enumerator-administered questionnaire, we collected data on the respondents' demographic characteristics, COVID-19 test history, COVID-19 symptoms in the last 14 days, comorbidities, and protective behaviours during the last month. We employed descriptive analysis to estimate the seroprevalence and IFR.<h4>Findings</h4>The prevalence of Antibody against SARS-CoV-2 was 28.52% (95% CI 25.44-31.81%), with the result being higher in females than males (OR 1.20; 95% CI 1.02-1.42). By the end of the data collection (February 9, 2021), the cumulative cases of COVID-19 in Tanjung Priok were reported to be experienced by 9,861 people (2.4%). Those aged 45-65 were more likely to be seropositive than 15-19 years old (OR 1.42; 95% CI 1.05-1.92). Nearly one third (31%) of the subjects who developed at least one COVID-19 symptom in the last 14 days of the data collection were seropositive. The estimated IFR was 0.08% (95% CI 0.07-0.09), with a higher figure recorded in males (0.09; 95% CI 0.08-0.10) than females (0.07; 95% CI 0.06-0.08), and oldest age group (45-65) (0.21; 95% CI 0.18-0.23) than other younger groups.<h4>Conclusion</h4>An under-reporting issue was found between the estimated COVID-19 seroprevalence and the reported cumulative cases in Tanjung Priok. More efforts are required to amplify epidemiological surveillance by the provincial and local governments.
format Article
id doaj-art-6df0c6f09fe74ee5b5eca1eca21a27f0
institution OA Journals
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-6df0c6f09fe74ee5b5eca1eca21a27f02025-08-20T02:22:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-011612e026193110.1371/journal.pone.0261931Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.Olivia HerlindaAdrianna BellaGita KusnadiDimitri Swasthika NurshadrinaMochamad Thoriq AkbarSofwatun NidaNgabila SalamaIwan AriawanDiah Saminarsih<h4>Background</h4>Understanding the actual prevalence of COVID-19 transmission in the community is vital for strategic responses to the pandemic. This study aims to estimate the actual infection of COVID-19 through a seroprevalence survey and to predict infection fatality rate (IFR) in Tanjung Priok, the hardest-hit sub-district by the COVID-19 in Jakarta, Indonesia.<h4>Methods</h4>We conducted a venous blood sampling (phlebotomy) to 3,196 individuals in Tanjung Priok between Nov 23, 2020, and Feb 19, 2021 to detect their antibodies against SARS-CoV-2. Using an enumerator-administered questionnaire, we collected data on the respondents' demographic characteristics, COVID-19 test history, COVID-19 symptoms in the last 14 days, comorbidities, and protective behaviours during the last month. We employed descriptive analysis to estimate the seroprevalence and IFR.<h4>Findings</h4>The prevalence of Antibody against SARS-CoV-2 was 28.52% (95% CI 25.44-31.81%), with the result being higher in females than males (OR 1.20; 95% CI 1.02-1.42). By the end of the data collection (February 9, 2021), the cumulative cases of COVID-19 in Tanjung Priok were reported to be experienced by 9,861 people (2.4%). Those aged 45-65 were more likely to be seropositive than 15-19 years old (OR 1.42; 95% CI 1.05-1.92). Nearly one third (31%) of the subjects who developed at least one COVID-19 symptom in the last 14 days of the data collection were seropositive. The estimated IFR was 0.08% (95% CI 0.07-0.09), with a higher figure recorded in males (0.09; 95% CI 0.08-0.10) than females (0.07; 95% CI 0.06-0.08), and oldest age group (45-65) (0.21; 95% CI 0.18-0.23) than other younger groups.<h4>Conclusion</h4>An under-reporting issue was found between the estimated COVID-19 seroprevalence and the reported cumulative cases in Tanjung Priok. More efforts are required to amplify epidemiological surveillance by the provincial and local governments.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261931&type=printable
spellingShingle Olivia Herlinda
Adrianna Bella
Gita Kusnadi
Dimitri Swasthika Nurshadrina
Mochamad Thoriq Akbar
Sofwatun Nida
Ngabila Salama
Iwan Ariawan
Diah Saminarsih
Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.
PLoS ONE
title Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.
title_full Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.
title_fullStr Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.
title_full_unstemmed Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.
title_short Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.
title_sort seroprevalence of antibodies against sars cov 2 in the high impacted sub district in jakarta indonesia
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261931&type=printable
work_keys_str_mv AT oliviaherlinda seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT adriannabella seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT gitakusnadi seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT dimitriswasthikanurshadrina seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT mochamadthoriqakbar seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT sofwatunnida seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT ngabilasalama seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT iwanariawan seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia
AT diahsaminarsih seroprevalenceofantibodiesagainstsarscov2inthehighimpactedsubdistrictinjakartaindonesia